Direct-to-Consumer Genetic Testing Market by Type, Channel, Function - Global Forecast 2025-2030- Product Image

Sale

Direct-to-Consumer Genetic Testing Market by Type, Channel, Function - Global Forecast 2025-2030

Report
182 Pages
October 2024
Region: Global
360iResearch™
ID: 4968843

UP TO €681EUR$697USD£568GBP OFF until Dec 31^st 2024

The Direct-to-Consumer Genetic Testing Market grew from USD 2.02 billion in 2023 to USD 2.36 billion in 2024. It is expected to continue growing at a CAGR of 17.21%, reaching USD 6.15 billion by 2030.

The direct-to-consumer (DTC) genetic testing market involves providing consumers access to genetic analysis without the need for healthcare provider mediation. This market includes tests for ancestry, health risks, traits, and wellness, catering to individuals seeking personal insights into their genetic makeup. The necessity of these tests is driven by rising consumer awareness and demand for personalized healthcare solutions, which allow individuals to proactively manage their health. Applications span from ancestry tracing to predictive health analytics, enabling tailored lifestyle and health management strategies. Key end-users include consumers interested in ancestry, health-conscious individuals, wellness enthusiasts, and healthcare professionals seeking supplementary insights. Market growth is influenced by factors such as increasing demand for personalized medicine, advancements in genomics, and reduced costs of genetic testing. Opportunities arise from technological advancements and growing consumer engagement, shifting the focus toward expanded test offerings and improved accuracy. Companies can capitalize by enhancing consumer education and exploring partnerships with healthcare providers for seamless integration of genetic insights into clinical practice. However, growth is challenged by privacy concerns, regulatory scrutiny, and potential misuse of genetic information. The market faces limitations in the accuracy of predictions and comprehensiveness of tests, necessitating robust data protection protocols and transparent communication of test limitations. Innovation opportunities lie in refining algorithms for data analysis, integrating artificial intelligence for personalized recommendations, and developing comprehensive genomic databases to improve predictive accuracy. Research into consumer behavior and preferences can yield insights essential for crafting effective marketing strategies. Collaborative efforts in data sharing and standardizing ethical guidelines can enhance trust and facilitate market expansion. The market is dynamic, with trends leaning towards consumer empowerment and deeper integration into health ecosystems, demanding continued innovation and strategic alignment with consumer expectations and regulatory frameworks.

Understanding Market Dynamics in the Direct-to-Consumer Genetic Testing Market

The Direct-to-Consumer Genetic Testing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Paradigm shift among consumers seeking greater control over their own healthcare
- Rising awareness about genome testing and risk of genetic diseases
- High aging population coupled with growing prevalence of chronic disorders
- Increased inquisitiveness about the assessment of lineage and ancestry
Market Restraints
- Related scientific, technical, and clinical issues
- First amendment issues of honesty, fidelity to facts, and truth-in-advertising
Market Opportunities
- Next-generation sequencing and bio-chip for present and future genetic diagnosis
- Development of online applications to serve customer needs
Market Challenges
- Complexity of test result interpretation
- Lack of adequate physician knowledge about genetics

Exploring Porter’s Five Forces for the Direct-to-Consumer Genetic Testing Market

Porter’s Five Forces framework further strengthens the insights of the Direct-to-Consumer Genetic Testing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Direct-to-Consumer Genetic Testing Market

External macro-environmental factors deeply influence the performance of the Direct-to-Consumer Genetic Testing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Direct-to-Consumer Genetic Testing Market

The Direct-to-Consumer Genetic Testing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Direct-to-Consumer Genetic Testing Market

The Direct-to-Consumer Genetic Testing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Direct-to-Consumer Genetic Testing Market

The Direct-to-Consumer Genetic Testing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Direct-to-Consumer Genetic Testing Market, highlighting leading vendors and their innovative profiles. These include Ancestry.com LLC, Dante Labs Inc., EasyDNA, FamilyTreeDNA by Gene, Ltd., Genesis Healthcare Co., Helix OpCo, LLC, Karmagenes SA, Living DNA Ltd., Mapmygenome, Merck KGaA, MyHeritage Ltd., Positive Biosciences, Ltd., Shuwen Biotech Co. Ltd., Vitagene, Inc., and Xcode Life.

Market Segmentation & Coverage

This research report categorizes the Direct-to-Consumer Genetic Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Mitochondrial DNA Testing
- Single Nucleotide Polymorphism Testing
- Y Chromosome Testing
Channel
- Offline
- Online
Function
- Ancestry & Ethnicity
- Cancer Screening
  - Hereditary Cancer
    - Blood Cancer
    - Breast Cancer
    - Ovarian Cancer
  - Sporadic Cancer
- Genetic Disease Carrier Status
- New Baby Screening
- Traits
- Wellness

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Paradigm shift among consumers seeking greater control over their own healthcare
5.1.1.2. Rising awareness about genome testing and risk of genetic diseases
5.1.1.3. High aging population coupled with growing prevalence of chronic disorders
5.1.1.4. Increased inquisitiveness about the assessment of lineage and ancestry
5.1.2. Restraints
5.1.2.1. Related scientific, technical, and clinical issues
5.1.2.2. First amendment issues of honesty, fidelity to facts, and truth-in-advertising
5.1.3. Opportunities
5.1.3.1. Next-generation sequencing and bio-chip for present and future genetic diagnosis
5.1.3.2. Development of online applications to serve customer needs
5.1.4. Challenges
5.1.4.1. Complexity of test result interpretation
5.1.4.2. Lack of adequate physician knowledge about genetics
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Direct-to-Consumer Genetic Testing Market, by Type

6.1. Introduction
6.2. Mitochondrial DNA Testing
6.3. Single Nucleotide Polymorphism Testing
6.4. Y Chromosome Testing

7. Direct-to-Consumer Genetic Testing Market, by Channel

7.1. Introduction
7.2. Offline
7.3. Online

8. Direct-to-Consumer Genetic Testing Market, by Function

8.1. Introduction
8.2. Ancestry & Ethnicity
8.3. Cancer Screening
8.3.1. Hereditary Cancer
8.3.1.1. Blood Cancer
8.3.1.2. Breast Cancer
8.3.1.3. Ovarian Cancer
8.3.2. Sporadic Cancer
8.4. Genetic Disease Carrier Status
8.5. New Baby Screening
8.6. Traits
8.7. Wellness

9. Americas Direct-to-Consumer Genetic Testing Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Direct-to-Consumer Genetic Testing Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Direct-to-Consumer Genetic Testing Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. DIRECT-TO-CONSUMER GENETIC TESTING MARKET RESEARCH PROCESS
FIGURE 2. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. DIRECT-TO-CONSUMER GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DIRECT-TO-CONSUMER GENETIC TESTING MARKET DYNAMICS
TABLE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL DNA TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SINGLE NUCLEOTIDE POLYMORPHISM TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY Y CHROMOSOME TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY & ETHNICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SPORADIC CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GENETIC DISEASE CARRIER STATUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEW BABY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 44. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 47. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 48. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 52. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 53. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 71. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 74. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 75. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 76. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 79. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 80. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 89. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 90. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 119. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 120. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 135. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 136. DENMARK DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 140. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 141. EGYPT DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 145. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 146. FINLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 150. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 151. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 155. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 156. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 162. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 165. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 166. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 180. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 181. NORWAY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 182. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 185. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 186. POLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 187. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 190. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 191. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 210. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 211. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 226. TURKEY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2030 (USD MILLION)
TABLE 237. DIRECT-TO-CONSUMER GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 238. DIRECT-TO-CONSUMER GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Direct-to-Consumer Genetic Testing Market, which are profiled in this report, include:

Ancestry.com LLC
Dante Labs Inc.
EasyDNA
FamilyTreeDNA by Gene, Ltd.
Genesis Healthcare Co.
Helix OpCo, LLC
Karmagenes SA
Living DNA Ltd.
Mapmygenome
Merck KGaA
MyHeritage Ltd.
Positive Biosciences, Ltd.
Shuwen Biotech Co. Ltd.
Vitagene, Inc.
Xcode Life

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	182
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 2.36 Billion
Forecasted Market Value ( USD ) by 2030	$ 6.15 Billion
Compound Annual Growth Rate	17.2%
Regions Covered	Global
No. of Companies Mentioned	15

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3464EUR$3,545USD£2,892GBP €3849EUR$3,939USD£3,213GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6128EUR$6,272USD£5,116GBP €6809EUR$6,969USD£5,684GBP

Understanding Market Dynamics in the Direct-to-Consumer Genetic Testing Market

Exploring Porter’s Five Forces for the Direct-to-Consumer Genetic Testing Market

Applying PESTLE Analysis to the Direct-to-Consumer Genetic Testing Market

Analyzing Market Share in the Direct-to-Consumer Genetic Testing Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Direct-to-Consumer Genetic Testing Market

Strategic Recommendations for Success in the Direct-to-Consumer Genetic Testing Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Direct-To-Consumer (DTC) Genetic Testing - Market Insights, Competitive Landscape, and Market Forecast - 2030

Genetic Testing Market by Product, Test Type, Technology, Application, Distribution Channel, End-User - Global Forecast 2025-2030

Genetic Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 To 2032

Predictive Genetic Testing and Consumer Genomics Market Size, Share & Trends Analysis Report by Test, Application, Setting (DTC, Professional), Region, and Segment Forecasts, 2025-2030

Global Hereditary Genetic Testing Market: Focus on Product, Sample Type, Technology, Genetic Testing Type, Application Area, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033

About the Direct to Consumer Genetic Testing Market